Date of Award
Honors Thesis (Colby Access Only)
Colby College. Economics Dept.
Randy A. Nelson
David W. Findlay
The scope of investment managers has increased to include many niche strategies such as predicting drug development outcomes. Pharmaceutical firms must submit a New Drug Application to the U.S. Food and Drug Administration after the completion of their clinical trials in order to get the final regulatory approval before they can market the drug. In this paper, I search for the stock market’s ability to accurately predict designations before the actual announcement for 116 PDUFA dates. I find that the market is able to predict approval designations by the FDA and that this predictive power is stronger for smaller capitalization firms.
medicine, food and drug administration, markets
Recommended CitationAbe, Thomas D., "Can the Stock Market Predict FDA Approvals for New Drug Applications?" (2013). Honors Theses. Paper 672.
Colby College theses are protected by copyright. They may be viewed or downloaded from this site for the purposes of research and scholarship. Reproduction or distribution for commercial purposes is prohibited without written permission of the author.